Summary
Performance
Immunogen
Application
Background
Converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilator. Has also a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. Converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilator. Has also a glycosidase activity which releases GPI- anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety.
Research Area
Cardiovascular; Blood; Serum Proteins; Stem Cells; Hematopoietic Progenitors; Surface Molecules; Signal Transduction; Metabolism; Vitamins / Minerals; Cell Biology; Proteolysis / Ubiquitin; Proteolytic enzymes; Metalloprotease; ACEs; Vasculature; Vasoconstriction; Cancer; Cancer Metabolism; Response to hypoxia; Kits/ Lysates/ Other; Kits; ELISA Kits; Cardiovascular ELISA kits; Metabolism; Pathways and Processes; Cofactors, Vitamins / minerals; Hypoxia
